Darrell Irvine News Today

Elicio Therapeutics is testing a pancreatic cancer vaccine using technology first developed at MIT in clinical trials, with promising Phase 1 results.

Vaccines that target tumors with specific genetic mutations in pancreatic and other cancers have shown promise in early-stage trials

Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.

<p>Using a DNA-based delivery particle, researchers created a vaccine that can induce a strong antibody response against SARS-CoV-2.</p>

MIT and Ragon Institute create SARS-CoV-2 vaccine using DNA particles for effective antibody response.

MIT and Ragon Institute create SARS-CoV-2 vaccine using DNA particles for effective antibody response.

On Nov. 7, a team from the Marble Center for Cancer Nanomedicine at MIT showed a Washington audience several examples of how nanotechnologies developed at the Institute can transform the detection and treatment of cancer and other diseases.The team w

At a White House Demo Day, a team from the Marble Center for Cancer Nanomedicine at the MIT Koch Institute for Integrative Cancer Research showcased nanotechnologies designed to improve the detection and treatment of cancer and other diseases.

MIT Professor Darrell Irvine describes a novel vaccine adjuvant: a nanoparticle that can help stimulate the immune system to generate a stronger response to a vaccine. An HIV vaccine with this adjuvant will be tested in clinical trials.

/PRNewswire/ -- The Mark Foundation for Cancer Research announced 16 outstanding projects in its latest class of ASPIRE awards, granting more than $5 million...